Classification
Product TypeIngredient
Product FormPowder (active ingredient) / finished supplement dosage forms
Industry PositionNutraceutical (dietary supplement) active ingredient
Market
In Peru, coenzyme Q10 (CoQ10/ubidecarenone) is primarily positioned as a dietary-supplement ingredient and as a finished dietetic product sold in oral dosage forms. Market access risk is driven by regulatory classification: dietetic products in pharmaceutical-type presentations are handled under DIGEMID pathways, while foods and food-type products fall under DIGESA sanitary registration regimes. For imported products that require sanitary registration, Peru’s VUCE process and dossier completeness (e.g., free-sale documentation, lab analyses, labeling declarations) are common gating items. As a result, compliance readiness and documentation discipline tend to matter more than seasonality or domestic production factors for this product-country profile.
Market RoleImport-dependent consumer and formulation market (dietary supplements)
Domestic RoleDietary supplement ingredient and finished dietetic product used in oral supplementation
Market GrowthNot Mentioned
Specification
Primary VarietyCoenzyme Q10 (ubidecarenone; ubiquinone-10)
Secondary Variety- Ubiquinol-10 (reduced coenzyme Q10)
Physical Attributes- Lipid-soluble ubiquinone compound used as a dietary-supplement ingredient.
Compositional Metrics- Identity references often include CAS 303-98-0 and PubChem CID 5281915 for CoQ10 (molecular formula C59H90O4).
Supply Chain
Value Chain- Overseas manufacturer (CoQ10 ingredient or finished dosage form) → Peruvian importer/registrant → VUCE processing (as applicable) → SUNAT customs clearance → national distribution to retail or institutional channels
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighMisclassification between DIGEMID-regulated dietetic products (e.g., pharmaceutical-type oral dosage forms) and DIGESA-regulated foods can block or delay VUCE processing, customs clearance, and lawful commercialization of CoQ10 products in Peru.Confirm the intended presentation/claims and Peru regulatory classification before shipment; align the VUCE pathway (DIGEMID vs DIGESA) and ensure the local importer/registrant holds the required authorization/registration for the exact formula, dosage form, manufacturer, and country.
Documentation MediumSanitary registration dossiers for imported products (where applicable) can require free-sale/use certificates, labeling declarations, and laboratory analyses; gaps or mismatches can trigger rework and clearance delays.Build a pre-shipment compliance checklist aligned to the specific TUPA/authority workflow; secure accredited lab results and ensure label content and storage/shelf-life statements match the dossier.
Quality Assurance MediumDietetic product registration emphasizes quality and safety; insufficient manufacturing quality documentation or inconsistency in active-ingredient strength/description by dosage form can lead to registration denial or post-market enforcement.Use GMP/BPM-qualified manufacturers and maintain batch COA, stability rationale, and traceability records consistent with the registered dossier and labeling.
Logistics LowAlthough CoQ10 is relatively value-dense, VUCE and customs processing time can still create stockout risk for importers operating with low inventory buffers.Plan lead times around VUCE processing and customs variability; maintain safety stock for regulated SKUs.
Standards- Buenas Prácticas de Manufactura (BPM/GMP) evidence and quality documentation are relevant in registration workflows for dietetic products (DIGEMID) and in sanitary registration dossiers where applicable.
FAQ
Which Peruvian authority is relevant for registering coenzyme Q10 supplements?It depends on the product’s presentation and claims. DIGEMID covers “producto dietético” registrations for oral pharmaceutical-type dosage forms (e.g., tablets/capsules) via VUCE, while DIGESA handles sanitary registration for foods and beverages (and related categories) under its food control framework.
What paperwork tends to drive delays for imported CoQ10 products that require sanitary registration in Peru?For products that fall under DIGESA sanitary registration, common gating items include the VUCE/SUCE filing, a valid free-sale/use certificate from the manufacturing country’s competent authority (when required), required laboratory analyses from qualified/accredited labs, and correct labeling declarations and dossier details (storage, shelf life, lot identification).
What is the single biggest deal-breaker risk for bringing CoQ10 products into Peru?Regulatory misclassification or incomplete registration documentation. If the product is routed through the wrong authority pathway (DIGEMID vs DIGESA) or the VUCE dossier does not match the exact formula/dosage form/manufacturer details, the shipment can be delayed and the product may not be lawfully commercialized.